Estimating metabolic rate for butadiene at steady state using a Bayesian physiologically-based pharmacokinetic model

In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, an...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental and ecological statistics Vol. 18; no. 1; pp. 131 - 146
Main Authors Ngo, Long, Ryan, Louise M, Mezzetti, Maura, Bois, Frédéric Y, Smith, Thomas J
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.03.2011
Springer Nature B.V
Springer Verlag (Germany)
Subjects
Online AccessGet full text
ISSN1352-8505
1573-3009
DOI10.1007/s10651-009-0124-1

Cover

Abstract In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from −5.63 to −0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.
AbstractList In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from -5.63 to -0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.
In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from −5.63 to −0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.
In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7–17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from −5.63 to −0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64–1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.
In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20 min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40 min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from -5.63 to -0.30%. Those older than 30 years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2 ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.[PUBLICATION ABSTRACT]
In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to estimate the percentage of BD concentration metabolized at steady state, and to determine whether this percentage varies across gender, racial, and age groups. During the 20min of continuous exposure to 2 parts per million (ppm) of BD, five measurements of exhaled concentration were made on each subject. In the following 40min washout period, another five measurements were collected. A Bayesian hierarchical compartmental physiologically-based pharmacokinetic model (PKPB) was used. Using prior information on the model parameters, Markov Chain Monte Carlo (MCMC) simulation was conducted to obtain posterior distributions. The overall estimate of the mean percent of BD metabolized at steady state was 12.7% (95% credible interval: 7.7-17.8%). There was no significant difference in gender with males having a mean of 13.5%, and females 12.3%. Among the racial groups, Hispanic (13.9%), White (13.0%), Asian (12.1%), and Black (10.9%), the significant difference came from the difference between Black and Hispanic with a 95% credible interval from -5.63 to -0.30%. Those older than 30years had a mean of 12.2% versus 12.9% for the younger group; although this was not a statistically significant difference. Given a constant inhalation input of 2ppm, at steady state, the overall mean exhaled concentration was estimated to be 1.75ppm (95% credible interval: 1.64-1.84). An equivalent parameter, first-order metabolic rate constant, was also estimated and found to be consistent with the percent of BD metabolized at steady state across gender, race, and age strata.
Author Mezzetti, Maura
Smith, Thomas J
Ngo, Long
Ryan, Louise M
Bois, Frédéric Y
Author_xml – sequence: 1
  fullname: Ngo, Long
– sequence: 2
  fullname: Ryan, Louise M
– sequence: 3
  fullname: Mezzetti, Maura
– sequence: 4
  fullname: Bois, Frédéric Y
– sequence: 5
  fullname: Smith, Thomas J
BackLink https://ineris.hal.science/ineris-00963266$$DView record in HAL
BookMark eNqFkk1v1DAQhi1UJNqFH8CJiAscCIwdf8THtioUaSUO0LM1GztblyRebAcp_x5HQSBxKAdrrJlnXvkdzwU5m8LkCHlJ4T0FUB8SBSloDaBroIzX9Ak5p0I1dVNSZ-XeCFa3AsQzcpHSAwBwysQ5yTcp-xGzn47V6DIewuC7KmJ2VR9idZgzWu8mV2GuUnZolxLW6pzWFqyucHHJ41Sd7pfkwxCOvsNhWOoDJmdLFuOIXfjuJ5eL8hisG56Tpz0Oyb34HXfk7uPNt-vbev_l0-fry33dcalzzfq-uOKWMWxVS5lT4Kzlh77TUljLROOgV51kWotOU6FLjUsnLYBomaXNjrzbdO9xMKdYfMbFBPTm9nJvyoOiT6aMRzZMyp8r_mbDTzH8mF3KZvSpc8OAkwtzMq3kjdZKqUK-fZSkBaIKuJL_R6VshAZetHfk9T_oQ5jjVCZkWsFp-U61QnSDuhhSiq7_Y4yCWVfBbKuwGjPrKpjVGNt6UmGno4t_hR9rerU19RgMHtdZ3X1lQDmUw5SQzS9rR8Ch
Cites_doi 10.1080/15298668791385723
10.1289/ehp.02110165
10.1016/0300-483X(96)03462-2
10.1016/0300-483X(96)03464-6
10.1016/0300-483X(96)03463-4
10.1289/ehp.102-1567096
10.1016/0300-483X(96)03466-X
10.2307/3454324
10.1289/ehp.01109921
10.1016/0300-483X(96)03461-0
10.1093/carcin/14.4.619
10.1016/0300-483X(96)03465-8
10.1093/toxsci/49.2.213
10.2307/2291566
ContentType Journal Article
Copyright Springer Science+Business Media, LLC 2009
Springer Science+Business Media, LLC 2011
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Springer Science+Business Media, LLC 2009
– notice: Springer Science+Business Media, LLC 2011
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID FBQ
AAYXX
CITATION
3V.
7SN
7ST
7UA
7WY
7WZ
7XB
87Z
88I
8AL
8FD
8FE
8FG
8FH
8FK
8FL
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BEZIV
BGLVJ
BHPHI
BKSAR
C1K
CCPQU
DWQXO
F1W
FR3
FRNLG
F~G
GNUQQ
H97
HCIFZ
JQ2
K60
K6~
K7-
L.-
L.G
LK8
M0C
M0N
M2P
M7P
P5Z
P62
P64
PATMY
PCBAR
PHGZM
PHGZT
PKEHL
PQBIZ
PQBZA
PQEST
PQGLB
PQQKQ
PQUKI
PYCSY
Q9U
RC3
SOI
7S9
L.6
7SU
KR7
1XC
DOI 10.1007/s10651-009-0124-1
DatabaseName AGRIS
CrossRef
ProQuest Central (Corporate)
Ecology Abstracts
Environment Abstracts
Water Resources Abstracts
ABI/INFORM Collection
ABI/INFORM Global (PDF only)
ProQuest Central (purchase pre-March 2016)
ABI/INFORM Global (Alumni Edition)
Science Database (Alumni Edition)
Computing Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ABI/INFORM Collection (Alumni)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Business Premium Collection
Technology Collection (via ProQuest SciTech Premium Collection)
Natural Science Collection
Earth, Atmospheric & Aquatic Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
Business Premium Collection (Alumni)
ABI/INFORM Global (Corporate)
ProQuest Central Student
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
SciTech Premium Collection
ProQuest Computer Science Collection
ProQuest Business Collection (Alumni Edition)
ProQuest Business Collection
Computer Science Database
ABI/INFORM Professional Advanced
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest Biological Science Collection
ABI/INFORM Global
Computing Database
Science Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Earth, Atmospheric & Aquatic Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest One Business (OCUL)
ProQuest One Business (Alumni)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Environmental Science Collection
ProQuest Central Basic
Genetics Abstracts
Environment Abstracts
AGRICOLA
AGRICOLA - Academic
Environmental Engineering Abstracts
Civil Engineering Abstracts
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
ProQuest Business Collection (Alumni Edition)
Computer Science Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Computer Science Collection
SciTech Premium Collection
ABI/INFORM Complete
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Water Resources Abstracts
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Natural Science Collection
Biological Science Collection
ProQuest Central (New)
Advanced Technologies & Aerospace Collection
Business Premium Collection
ABI/INFORM Global
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Earth, Atmospheric & Aquatic Science Database
ProQuest Technology Collection
Biological Science Database
ProQuest Business Collection
Ecology Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
ProQuest One Academic UKI Edition
Environmental Science Database
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ABI/INFORM Global (Corporate)
ProQuest One Business
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
Earth, Atmospheric & Aquatic Science Collection
ABI/INFORM Professional Advanced
Genetics Abstracts
ProQuest Central Korea
Agricultural & Environmental Science Collection
ABI/INFORM Complete (Alumni Edition)
ProQuest Computing
ABI/INFORM Global (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest Computing (Alumni Edition)
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ASFA: Aquatic Sciences and Fisheries Abstracts
ProQuest One Business (Alumni)
Environment Abstracts
ProQuest Central (Alumni)
Business Premium Collection (Alumni)
AGRICOLA
AGRICOLA - Academic
Civil Engineering Abstracts
Environmental Engineering Abstracts
DatabaseTitleList
AGRICOLA

ProQuest Business Collection (Alumni Edition)
Civil Engineering Abstracts
Civil Engineering Abstracts

Database_xml – sequence: 1
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
– sequence: 2
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Geology
Statistics
Environmental Sciences
Medicine
Computer Science
Ecology
Physics
Public Health
EISSN 1573-3009
EndPage 146
ExternalDocumentID oai_HAL_ineris_00963266v1
2279085571
10_1007_s10651_009_0124_1
US201400142756
Genre Feature
GroupedDBID -4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
3-Y
30V
3V.
4.4
406
408
409
40D
40E
4P2
53G
5GY
5QI
5VS
67M
67Z
6NX
78A
7WY
7XC
88I
8CJ
8FE
8FG
8FH
8FL
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABELW
ABFGW
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTAH
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACGOD
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACSNA
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOAH
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFEXP
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOSHJ
ARAPS
ARMRJ
ASPBG
ATCPS
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BEZIV
BGLVJ
BGNMA
BHPHI
BKSAR
BPHCQ
CAG
CCPQU
COF
CS3
CSCUP
D1J
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EDH
EIOEI
EJD
ESBYG
FBQ
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRNLG
FRRFC
FSGXE
FWDCC
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GROUPED_ABI_INFORM_COMPLETE
GXS
HCIFZ
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
H~9
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K60
K6V
K6~
K7-
KDC
KOV
KOW
L8X
LAK
LK8
LLZTM
M0C
M0N
M2P
M4Y
M7P
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P62
PATMY
PCBAR
PF0
PQBIZ
PQQKQ
PROAC
PT4
PT5
PYCSY
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK6
WK8
YLTOR
Z45
ZMTXR
ZOVNA
ZY4
~02
~A9
~EX
~KM
AACDK
AAHBH
AAJBT
AASML
AAYZH
ABAKF
ABQSL
ACAOD
ACDTI
ACPIV
ACZOJ
AEFQL
AEMSY
AEUYN
AFBBN
AGQEE
AGRTI
AIGIU
BSONS
H13
PQBZA
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
7SN
7ST
7UA
7XB
8AL
8FD
8FK
ABRTQ
C1K
F1W
FR3
H97
JQ2
L.-
L.G
P64
PKEHL
PQEST
PQGLB
PQUKI
Q9U
RC3
SOI
7S9
L.6
PUEGO
7SU
KR7
1XC
ID FETCH-LOGICAL-c469t-2ff1064d22a87812e70edd4bfc965dd253e0f7c62995c9159d4b46e6d00582d13
IEDL.DBID 8FG
ISSN 1352-8505
IngestDate Fri May 09 12:27:40 EDT 2025
Thu Sep 04 19:28:48 EDT 2025
Thu Sep 04 22:29:03 EDT 2025
Thu Sep 04 23:46:41 EDT 2025
Fri Jul 25 19:05:39 EDT 2025
Tue Jul 01 04:38:00 EDT 2025
Fri Feb 21 02:42:01 EST 2025
Wed Dec 27 19:25:38 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Bayesian hierarchical model
Compartmental model
Differential equation
Random effects
Markov Chain Monte Carlo
Metabolic rate constant
Steady state
Nonlinear model
Language English
License http://www.springer.com/tdm
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-2ff1064d22a87812e70edd4bfc965dd253e0f7c62995c9159d4b46e6d00582d13
Notes http://dx.doi.org/10.1007/s10651-009-0124-1
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
OpenAccessLink http://hdl.handle.net/2108/37091
PQID 854115774
PQPubID 23500
PageCount 16
ParticipantIDs hal_primary_oai_HAL_ineris_00963266v1
proquest_miscellaneous_864399777
proquest_miscellaneous_1777170476
proquest_miscellaneous_1663590464
proquest_journals_854115774
crossref_primary_10_1007_s10651_009_0124_1
springer_journals_10_1007_s10651_009_0124_1
fao_agris_US201400142756
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-03-01
PublicationDateYYYYMMDD 2011-03-01
PublicationDate_xml – month: 03
  year: 2011
  text: 2011-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: Dordrecht
PublicationTitle Environmental and ecological statistics
PublicationTitleAbbrev Environ Ecol Stat
PublicationYear 2011
Publisher Springer US
Springer Nature B.V
Springer Verlag (Germany)
Publisher_xml – name: Springer US
– name: Springer Nature B.V
– name: Springer Verlag (Germany)
References KohnMCMelnickRLPhysiological modeling of butadiene disposition in mice and ratsChem Biol Interact2001136135301
KohnMCMelnickRLThe privileged access model of 1,3-butadiene dispositionEnviron Health Perspect20001085911917110360001:CAS:528:DC%2BD3cXnvV2kt74%3D10.2307/3454324
Melnick RL, Huff JE (1993) 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8,000 parts per million. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: assessment of health hazards. IARC Scientific Publications No. 127, Lyon
BondJADahlARHendersonRFIrnbaumLSSpecies differences in the distribution of inhaled butadiene in tissuesAm Ind Hyg Assoc J19874886787236877321:CAS:528:DyaL2sXmtFehsLw%3D
KohnMCMelnickRLSpecies differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, controlCarcinogenesis19931461962884723251:CAS:528:DyaK3sXisV2lu78%3D10.1093/carcin/14.4.619
LangLBaffling butadieneEnviron Health Perspect1994102328228580338671:STN:280:DyaK2czgslagsw%3D%3D
Thornton-ManningRJDahlRABechtoldEWHendersonFRGender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposuresToxicology199611332232589019181:CAS:528:DyaK28XmvVCltLo%3D10.1016/0300-483X(96)03466-X
Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Bauer C, Csanády GA (1993) A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and Styrene: Assessment of Health Hazards, vol IARC Scientific Publications No. 127, Lyon
GelmanAEBoisFYJiangJPhysiological pharmacokinetics analysis using population modeling and informative prior distributionsJ Am Stat Assoc1996911400141210.2307/2291566
BoisFYSmithTJGelmanAEChangHYSmithAEOptimal design for a study of butadiene toxicokinetics in humansToxicol Sci199949213224104162661:CAS:528:DyaK1MXkt1yqurc%3D10.1093/toxsci/49.2.213
SweeneyMLHimmelsteinWMSchlosserMPMedinskyAMPhysiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadieneToxicology199611331832189019171:CAS:528:DyaK28XmvVCltL0%3D10.1016/0300-483X(96)03465-8
BoisFYMaszleDRMCSim: a Monte Carlo simulation programJ Stat Softw19972160
MezzettiMIbrahimJGBoisFYRyanLMNgoLSmithTJA Bayesian compartmental model for the evaluation of 1,3-Butadiene metabolismAppl Stat2003523291305
ShargelLYuAApplied biopharmaceutics and pharmacokinetics19994Stamford, CTAppleton and Lange3643
ATSDR (1993) ToxFAQsTM for 1,3-Butadiene. Atlanta, GA: U.S. Department of health and human services, Public Health Service. http://www.atsdr.cdc.gov/tfacts28.html. Accessed 20 Feb 2004
LeavensLTBondAJPharmacokinetic model describing the disposition of butadiene and styrene in miceToxicology199611331031389019151:CAS:528:DyaK28XmvVCltL8%3D10.1016/0300-483X(96)03463-4
HimmelsteinWMTurnerJMAsgharianBBondAJMetabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and miceToxicology199611330630989019141:CAS:528:DyaK28XmvVCltL4%3D10.1016/0300-483X(96)03462-2
LinYSSmithTJKelseyKTWypijDHuman physiologic factors in respiratory update of 1,3-butadieneEnviron Health Perspect2001109921926116731211:CAS:528:DC%2BD3MXnvVCkt78%3D10.1289/ehp.01109921
LinYSSmithTJWypijDKelseyKTSacksMFAssociation of blood/air partition coefficient of 1,3-butadiene with blood lipids and albuminEnviron Health Perspect20021102165168118361451:CAS:528:DC%2BD38Xit1ansL0%3D10.1289/ehp.02110165
SeatonJMPlopperGCBondAJ1,3-Butadiene metabolism by lung airways isolated from mice and ratsToxicology199611331431789019161:CAS:528:DyaK28XmvVCltLw%3D10.1016/0300-483X(96)03464-6
CsanadyAGKreuzerPEBaurCFilserJGA physiological toxicokinetic model for 1,3-Butadiene in rodents and man: blood concentrations of 1,3- butadiene, its metabolically form epoxides, and of haemoglobin adducts—relevance of glutathione depletionToxicology199611330030589019131:CAS:528:DyaK28XmvVClt7c%3D10.1016/0300-483X(96)03461-0
AE Gelman (124_CR7) 1996; 91
JM Seaton (124_CR18) 1996; 113
124_CR16
M Mezzetti (124_CR17) 2003; 52
AG Csanady (124_CR5) 1996; 113
RJ Thornton-Manning (124_CR21) 1996; 113
FY Bois (124_CR2) 1997; 2
L Lang (124_CR12) 1994; 102
L Shargel (124_CR19) 1999
ML Sweeney (124_CR20) 1996; 113
MC Kohn (124_CR10) 2000; 108
WM Himmelstein (124_CR8) 1996; 113
LT Leavens (124_CR13) 1996; 113
MC Kohn (124_CR9) 1993; 14
JA Bond (124_CR4) 1987; 48
124_CR6
124_CR1
YS Lin (124_CR14) 2001; 109
124_CR11
FY Bois (124_CR3) 1999; 49
YS Lin (124_CR15) 2002; 110
References_xml – reference: BoisFYSmithTJGelmanAEChangHYSmithAEOptimal design for a study of butadiene toxicokinetics in humansToxicol Sci199949213224104162661:CAS:528:DyaK1MXkt1yqurc%3D10.1093/toxsci/49.2.213
– reference: SeatonJMPlopperGCBondAJ1,3-Butadiene metabolism by lung airways isolated from mice and ratsToxicology199611331431789019161:CAS:528:DyaK28XmvVCltLw%3D10.1016/0300-483X(96)03464-6
– reference: KohnMCMelnickRLPhysiological modeling of butadiene disposition in mice and ratsChem Biol Interact2001136135301
– reference: ShargelLYuAApplied biopharmaceutics and pharmacokinetics19994Stamford, CTAppleton and Lange3643
– reference: ATSDR (1993) ToxFAQsTM for 1,3-Butadiene. Atlanta, GA: U.S. Department of health and human services, Public Health Service. http://www.atsdr.cdc.gov/tfacts28.html. Accessed 20 Feb 2004
– reference: HimmelsteinWMTurnerJMAsgharianBBondAJMetabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and miceToxicology199611330630989019141:CAS:528:DyaK28XmvVCltL4%3D10.1016/0300-483X(96)03462-2
– reference: Melnick RL, Huff JE (1993) 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8,000 parts per million. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: assessment of health hazards. IARC Scientific Publications No. 127, Lyon
– reference: MezzettiMIbrahimJGBoisFYRyanLMNgoLSmithTJA Bayesian compartmental model for the evaluation of 1,3-Butadiene metabolismAppl Stat2003523291305
– reference: BoisFYMaszleDRMCSim: a Monte Carlo simulation programJ Stat Softw19972160
– reference: LangLBaffling butadieneEnviron Health Perspect1994102328228580338671:STN:280:DyaK2czgslagsw%3D%3D
– reference: CsanadyAGKreuzerPEBaurCFilserJGA physiological toxicokinetic model for 1,3-Butadiene in rodents and man: blood concentrations of 1,3- butadiene, its metabolically form epoxides, and of haemoglobin adducts—relevance of glutathione depletionToxicology199611330030589019131:CAS:528:DyaK28XmvVClt7c%3D10.1016/0300-483X(96)03461-0
– reference: GelmanAEBoisFYJiangJPhysiological pharmacokinetics analysis using population modeling and informative prior distributionsJ Am Stat Assoc1996911400141210.2307/2291566
– reference: Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Bauer C, Csanády GA (1993) A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and Styrene: Assessment of Health Hazards, vol IARC Scientific Publications No. 127, Lyon
– reference: LinYSSmithTJKelseyKTWypijDHuman physiologic factors in respiratory update of 1,3-butadieneEnviron Health Perspect2001109921926116731211:CAS:528:DC%2BD3MXnvVCkt78%3D10.1289/ehp.01109921
– reference: LeavensLTBondAJPharmacokinetic model describing the disposition of butadiene and styrene in miceToxicology199611331031389019151:CAS:528:DyaK28XmvVCltL8%3D10.1016/0300-483X(96)03463-4
– reference: BondJADahlARHendersonRFIrnbaumLSSpecies differences in the distribution of inhaled butadiene in tissuesAm Ind Hyg Assoc J19874886787236877321:CAS:528:DyaL2sXmtFehsLw%3D
– reference: Thornton-ManningRJDahlRABechtoldEWHendersonFRGender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposuresToxicology199611332232589019181:CAS:528:DyaK28XmvVCltLo%3D10.1016/0300-483X(96)03466-X
– reference: LinYSSmithTJWypijDKelseyKTSacksMFAssociation of blood/air partition coefficient of 1,3-butadiene with blood lipids and albuminEnviron Health Perspect20021102165168118361451:CAS:528:DC%2BD38Xit1ansL0%3D10.1289/ehp.02110165
– reference: KohnMCMelnickRLSpecies differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, controlCarcinogenesis19931461962884723251:CAS:528:DyaK3sXisV2lu78%3D10.1093/carcin/14.4.619
– reference: KohnMCMelnickRLThe privileged access model of 1,3-butadiene dispositionEnviron Health Perspect20001085911917110360001:CAS:528:DC%2BD3cXnvV2kt74%3D10.2307/3454324
– reference: SweeneyMLHimmelsteinWMSchlosserMPMedinskyAMPhysiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadieneToxicology199611331832189019171:CAS:528:DyaK28XmvVCltL0%3D10.1016/0300-483X(96)03465-8
– volume: 48
  start-page: 867
  year: 1987
  ident: 124_CR4
  publication-title: Am Ind Hyg Assoc J
  doi: 10.1080/15298668791385723
– ident: 124_CR11
– volume: 110
  start-page: 165
  issue: 2
  year: 2002
  ident: 124_CR15
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.02110165
– volume: 113
  start-page: 306
  year: 1996
  ident: 124_CR8
  publication-title: Toxicology
  doi: 10.1016/0300-483X(96)03462-2
– volume: 113
  start-page: 314
  year: 1996
  ident: 124_CR18
  publication-title: Toxicology
  doi: 10.1016/0300-483X(96)03464-6
– ident: 124_CR6
– volume: 113
  start-page: 310
  year: 1996
  ident: 124_CR13
  publication-title: Toxicology
  doi: 10.1016/0300-483X(96)03463-4
– volume: 102
  start-page: 282
  issue: 3
  year: 1994
  ident: 124_CR12
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.102-1567096
– volume: 113
  start-page: 322
  year: 1996
  ident: 124_CR21
  publication-title: Toxicology
  doi: 10.1016/0300-483X(96)03466-X
– volume: 108
  start-page: 911
  issue: 5
  year: 2000
  ident: 124_CR10
  publication-title: Environ Health Perspect
  doi: 10.2307/3454324
– ident: 124_CR1
– ident: 124_CR16
– volume: 52
  start-page: 291
  issue: 3
  year: 2003
  ident: 124_CR17
  publication-title: Appl Stat
– start-page: 36
  volume-title: Applied biopharmaceutics and pharmacokinetics
  year: 1999
  ident: 124_CR19
– volume: 109
  start-page: 921
  year: 2001
  ident: 124_CR14
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.01109921
– volume: 2
  start-page: 1
  year: 1997
  ident: 124_CR2
  publication-title: J Stat Softw
– volume: 113
  start-page: 300
  year: 1996
  ident: 124_CR5
  publication-title: Toxicology
  doi: 10.1016/0300-483X(96)03461-0
– volume: 14
  start-page: 619
  year: 1993
  ident: 124_CR9
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/14.4.619
– volume: 113
  start-page: 318
  year: 1996
  ident: 124_CR20
  publication-title: Toxicology
  doi: 10.1016/0300-483X(96)03465-8
– volume: 49
  start-page: 213
  year: 1999
  ident: 124_CR3
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/49.2.213
– volume: 91
  start-page: 1400
  year: 1996
  ident: 124_CR7
  publication-title: J Am Stat Assoc
  doi: 10.2307/2291566
SSID ssj0004125
Score 1.8550329
Snippet In a study of 133 volunteer subjects, demographic, physiologic and pharmacokinetic data through exposure to 1,3-Butadiene (BD) were collected in order to...
SourceID hal
proquest
crossref
springer
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 131
SubjectTerms Age
Bayesian analysis
Biomedical and Life Sciences
breathing
Cancer
Carcinogens
Chemistry and Earth Sciences
Computer Science
Computer simulation
Differential equations
Ecology
Environmental Sciences
Estimates
Estimating techniques
females
Gender
gender differences
Health Sciences
Hispanic people
Hispanics
Human body
Inhalation
Intervals
Life Sciences
Males
Markov analysis
Markov chain
Markov chains
Math. Appl. in Environmental Science
Mathematical models
Medicine
Metabolism
Metabolites
Monkeys & apes
Monte Carlo methods
Monte Carlo simulation
Occupational safety
Pharmacokinetics
Physics
Public health
Race
Statistics for Engineering
Statistics for Life Sciences
Steady state
Studies
Theoretical Ecology/Statistics
Toxicology
Tumors
volunteers
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELagCNQLj0DVUIqMBBeQpV2vvY9jQGkjBFwgUm_Wxo-A2m4Q2SDl3_ONd7cpiCJxyCpaTxwn4_F8s_Ni7KXMVB60zoSUdRAqc4mossQLQI2ysrbENQbIfspnc_X-TJ_1edzrIdp9cEnGk_pasluuYfrG-B6pBEyeOxqmO0njXE52yZBp7LSaAlmIEvp9cGX-bYrflNHtUK9w_UoBkdfQ5h8O0qh3Th6y-z1g5JOOw4_YLd-M2IOhGQPvZXPE7k5j_entiB1Md8lr-GRPsQbJqe9J7n3sXeq4GWNALYb3CXh2dZsfs3aKN4RmmyW_9C22ysU3y6muBAfM5YtNG2PFPK9bHjfKlsfcJE6B9Ete87f11lOCJo_PToYj9mIrSG863O1KZp9jEfhGHjvyPGHzk-mXdzPRd2gQFmZ1K2QI-EuVA6PB1VT6IvHOqUWwVa6dkzrzSShsDp2nbQXkhDGV-9xRN0Pp0uyA7TWrxh8yXvrgPE48rQFIk9IulAWWK3XIKg-Iosbs9cAq870rxGF2JZeJrwZ8NcRXk47ZIZhp6iUOSjP_LMmMxItK3Y_ZK3D4agqqrj2bfDCUaQlasugAaPOfmOJo2AOmF-u1KbWi4kQFVvPiahTySE6WuvGrzdqkBOEqchj_g6YoYEUnqsBq-A00JUFFSEwxZm-GHbhbyI2__Ol_UR-x_e4ZOcXUPWN77Y-NPwbIahfPo1D9As1rGd0
  priority: 102
  providerName: Springer Nature
Title Estimating metabolic rate for butadiene at steady state using a Bayesian physiologically-based pharmacokinetic model
URI https://link.springer.com/article/10.1007/s10651-009-0124-1
https://www.proquest.com/docview/854115774
https://www.proquest.com/docview/1663590464
https://www.proquest.com/docview/1777170476
https://www.proquest.com/docview/864399777
https://ineris.hal.science/ineris-00963266
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxNBFD7YFqEgotHSbbWMoC_K4F5mb0-SSi6oFFED9WnY7MxGUDe12Qj5935ndjdRoX3IJuwMm0m-M3O-mXMjeh5GKqniOJJhWFRSRcaXeeRbCaqR5WWZ4eocZC-S6Uy9u4wvO9-cVedW2a-JbqE2y5LPyF9nseK8MKl6c_VLctEoNq52FTT26CCAomExz8aTXVhk4GquBuAYMoOm742abeRcEmMf7ZyFQiWDf9TSXlUscf3GrpF_8c7_TKVOA40f0P2OOophi_VDumPrAR2NdpFqaOym6mpAdyeuZu9mQPfaoznRRhwN6JAJZpuf-RE1I3xg1lovxE_bQCS4K-ePEKCzYr5unE-YFUUjnEBshItBEuwwvxCFOC82lgMxhTsj6ZfSHxvJ-tHgbpsa-zvYLL5RuMo7j2k2Hn15O5VdJQZZYvvcyLCq8IcpA0CBXhDa1LfGqHlV5klsTBhH1q_SMoFui8scDAltKrGJ4aqFoQmiI9qvl7U9JpHZylisbDFj6WflXJXgbFlcRbkFFVEeveyB0Fdtwg29S63MqGmgphk1HXh0DKh0scCCqGefQ94u4sUp7T16Afy2j-As2tPhB80RlejLOzcQ1-Q3HnHaI6y76bvSW2Hz6Nm2FfOOjSlFbZfrlQ6YquVsGL6lT5pit-yrFKMRN_TJmBJiZqQeverlazeQG3_5ya3DPqXD9uybfeWe0H5zvbZPQZ6a-ZmbImd0MJx8fT_C-_no4uMn3J2Fwz_YUxaw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9tnRCTEILCtDA-jMReQBaJY-fjAaENOjpWKgSrtDeTxk6RgHTQFJQ_iv-ROydpAWl720Ojqracq-58_p3vC-CJCGVUKBVyIbKCy9D4PA19yxFqJGmeJ_h0AbLjaDiRb8_U2Qb87nJhKKyy04lOUZt5TnfkzxMlqS5MLF-ef-fUNIqcq10HjUYqTmz9Cy22xYvj18jefSGOBqevhrxtKsBztAQrLooCrSBpkDYkJBA29q0xclrkaaSMESq0fhHnEapplad42OOYjGxkqAGfMEGI627ClqSE1h5sHQ7G7z-sEzED1-U1QFTDE8QWnRu1ydWLFFruLjxJSB78cxBuFtkcn58pGPMvpPufc9adeUe34GYLVtlBI123YcOWfdgZrHPjcLBVDos-XHvjugTXfbjRXAayJsepD9sEaZuK0HegGuAXwsnljH2zFQohTaWKFQwBNJsuKxeFZllWMSeCNXNZT4xC9GcsY4dZbSn1k7lbmU55f605ncgGf22KcX9B_IxvZK7Xz12YXAmbdqBXzku7CyyxhbGoSxVJj5_kU5kjSkxUEaYWwY_04GnHCH3elPjQ62LOxDWNXNPENR14sIus0tkMVbCefBRkoOKHiuh7sI_8Wy1BdbuHByNNOZw4l2xFhMrRT1xir-OwbhXGQq_E24PHq1Hc6eS-yUo7Xy50QOAwJVf0JXPiGO1zX8ZIDbtgTkIgFPdi7MGzTr7WhFz4z-9dSvYjuD48fTfSo-PxyR5sNzfvFKl3H3rVj6V9gNCtmj5sNwyDT1e9R_8ATuBQFg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9tQ6BJE4LCtGx8GIm9gKwljp2PB4QGa9exaUKCSnszaWwXCWgHTUH50_jvuHOSFpC2tz00qmrLuerO59_5vgCei1gmTqmYC1E4LmMT8jwOLUeokeVlmeHTB8ieJ8ORfHehLtbgd5cLQ2GVnU70itrMSrojP8iUpLowqTxwbVTE-6PB68vvnBpIkaO166bRSMiprX-h9TZ_dXKErN4XYtD_-HbI2wYDvESrsOLCObSIpEE6kahI2DS0xsixK_NEGSNUbEOXlgmqbFXmePDjmExsYqgZnzBRjOuuw600TnOy-7LB8SolM_L9XiPENzxDlNE5VJusvUShDe8DlYTk0T9H4rorZvj8TGGZf2He_9y0_vQb3IO7LWxlh42c3Yc1O-3Bdn-VJYeDrZqY9-D2se8XXPdgq7kWZE22Uw82Cdw2taEfQNXHL4SYpxP2zVYojjSValcwhNJsvKh8PJplRcW8MNbM5z8xCtafsIK9KWpLSaDM3890avxrzelsNvhrU5b7CyJpfCPzXX8ewuhGmLQNG9PZ1O4Ay6wzFrWqIjkKs3IsS8SLmXJxbhEGyQBedIzQl02xD70q60xc08g1TVzTUQA7yCpdTFAZ69EHQaYqfqicfgD7yL_lElTBe3h4pimbE-eS1YigOfmJS-x1HNat6pjrpaAH8Gw5inueHDnF1M4Wcx0RTMzJKX3NnDRFSz2UKVLDrpiTERzFXZkG8LKTrxUhV_7z3WvJfgp3cGfqs5Pz0z3YbK7gKWTvEWxUPxb2MWK4avzE7xYGn256e_4BfedS5g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimating+metabolic+rate+for+butadiene+at+steady+state+using+a+Bayesian+physiologically-based+pharmacokinetic+model&rft.jtitle=Environmental+and+ecological+statistics&rft.au=Ngo%2C+Long&rft.au=Ryan%2C+Louise+M&rft.au=Mezzetti%2C+Maura&rft.au=Bois%2C+Fr%C3%A9d%C3%A9ric+Y&rft.date=2011-03-01&rft.issn=1352-8505&rft.volume=18&rft.issue=1+p.131-146&rft.spage=131&rft.epage=146&rft_id=info:doi/10.1007%2Fs10651-009-0124-1&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-8505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-8505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-8505&client=summon